Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Coherus Bio (NQ: CHRS )

17.75 USD -0.31 (-1.72%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 532,641
Open 18.17
Bid (Size) 17.35 (2)
Ask (Size) 19.00 (4)
Prev. Close 18.06
Today's Range 17.63 - 18.26
52wk Range 12.21 - 22.22
Shares Outstanding 76,785,431
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Coherus BioSciences Mourns the Passing of Board Member Dr. Samuel Nussbaum
From GlobeNewswire News Releases
Coherus BioSciences Announces New Employment Inducement Grants
From GlobeNewswire News Releases

Performance

YTD
+4.97%
+4.97%
1 Month
-0.34%
-0.34%
3 Month
+17.71%
+17.71%
6 Month
+29.47%
+29.47%
1 Year
-3.38%
-3.38%

More News

Read More
Junshi Biosciences and Coherus to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemother
From GlobeNewswire News Releases
Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemother
From GlobeNewswire News Releases
Coherus and Junshi Biosciences Announce Results from Phase 3 Study of Toripalimab Published in September Issue of Nature Medicine
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Friday's After-Market Session
Tags CHRS MNPR CWBR
From Benzinga
Recap: Coherus BioSciences Q3 Earnings
Tags Benzinga Earnings BZI/Recaps
From Benzinga
Coherus Biosciences Reaches 80-Plus Relative Strength Rating Benchmark
From Investor's Business Daily
Coherus Biosciences Clears Technical Benchmark, Hitting 80-Plus RS Rating
From Investor's Business Daily
Coherus BioSciences, inc (CHRS) Q3 2021 Earnings Call Transcript
Tags CHRS Market News Recent Press Releases
From Motley Fool
Week in Review: Two China Affiliated Biopharmas Raise $585 Million in IPOs
From ChinaBio® Today
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.